Your browser doesn't support javascript.
loading
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.
Frigola, Joan; Carbonell, Caterina; Irazno, Patricia; Pardo, Nuria; Callejo, Ana; Cedres, Susana; Martinez-Marti, Alex; Navarro, Alejandro; Soleda, Mireia; Jimenez, Jose; Hernandez-Losa, Javier; Vivancos, Ana; Felip, Enriqueta; Amat, Ramon.
  • Frigola J; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Carbonell C; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Irazno P; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Pardo N; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Callejo A; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Cedres S; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Martinez-Marti A; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Navarro A; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Soleda M; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Jimenez J; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Hernandez-Losa J; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Vivancos A; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Felip E; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Amat R; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
J Immunother Cancer ; 10(4)2022 04.
Article en En | MEDLINE | ID: mdl-35477861
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article